Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
KalVista Pharmaceuticals (DE:4XC1)
FRANKFURT:4XC1
RESEARCH TOOLSreports
Holding DE:4XC1?
Track your performance easily
| Jul 24 | Apr 24 | Jan 24 | Oct 23 | Jul 23 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | - | - | - | - | - |
| Gross Profit | - | - | - | - | - |
| EBIT | $ -40.44M | $ -44.65M | $ -33.15M | $ -29.75M | $ -25.32M |
| EBITDA | $ -40.21M | $ -44.44M | $ -32.94M | $ -29.55M | $ -25.06M |
| Net Income Common Stockholders | $ -40.44M | $ -44.65M | $ -29.03M | $ -27.65M | $ -25.32M |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 174.27M | $ 210.40M | $ 75.59M | $ 103.17M | $ 123.26M |
| Total Assets | $ 200.20M | $ 235.40M | $ 113.97M | $ 138.74M | $ 160.33M |
| Total Debt | $ 6.25M | $ 7.32M | $ 7.44M | $ 7.69M | $ 7.99M |
| Net Debt | $ -168.02M | $ -203.08M | $ -68.14M | $ -95.48M | $ -115.27M |
| Total Liabilities | $ 27.40M | $ 28.82M | $ 25.39M | $ 24.30M | $ 21.00M |
| Stockholders Equity | $ 172.80M | $ 206.61M | $ 88.58M | $ 114.45M | $ 139.34M |
| Cash Flow | - | ||||
| Free Cash Flow | $ -40.24M | $ -15.12M | $ -27.68M | $ -20.03M | $ -26.74M |
| Operating Cash Flow | $ -40.22M | $ -15.11M | $ -27.57M | $ -19.82M | $ -26.73M |
| Investing Cash Flow | $ 37.16M | $ -126.19M | $ -6.70M | $ 28.56M | $ 19.61M |
| Financing Cash Flow | $ 3.00M | $ 150.10M | $ 284.00K | $ 128.00K | $ 204.00K |